Description:

CALGB-40502 Registration Worksheet Form Paclitaxel, Paclitaxel Albumin-Stabilized Nanoparticle Formulation, or Ixabepilone With or Without Bevacizumab in Treating Patients With Stage IIIC or Stage IV Breast Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=51FACCD6-7472-0406-E044-0003BA3F9857

Link:
https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=51FACCD6-7472-0406-E044-0003BA3F9857
Keywords:
  1. 8/26/12 8/26/12 -
  2. 1/9/15 1/9/15 - Martin Dugas
  3. 1/9/15 1/9/15 - Martin Dugas
  4. 9/17/21 9/17/21 -
Uploaded on:

September 17, 2021

DOI:
To request one please log in.
License :
Creative Commons BY-NC 3.0 Legacy
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Breast Cancer NCT00785291 Registration - CALGB-40502 Registration Worksheet Form - 2765448v1.0

Endocrine Therapy in Combination with Anti-VEGF Therapy: A Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Endocrine Therapy Alone or Endocrine Therapy plus for Women with Hormone Receptor-Positive Advanced Breast Cancer

Protocol Administration
Patient Demographics/pre-treatment Characteristics
Gender
Patient Demographics/pre-treatment Characteristics
Race (Mark all that apply)
Ethnicity (Mark one)
Patient Demographics/pre-treatment Characteristics2
Patient Demographics/pre-treatment Characteristics2
Performance Status (ECOG/Zubrod scale)
cm
Kg
Disease name
Stage
Certification Of Eligibility And Protocol Design
In the opinion of the investigator, is the patient eligible
Certification Of Eligibility And Protocol Design
Prior Taxane as Adjuvant therapy or Neoadjuvant therapy
Receptor Status (ER/PgR status)
Physician's decision to use bevacizumab
Assigned Treatment Arm
Companion Study Calgb - 150714
Patient's Initial Consent given for specimen use for research on the patient's cancer (150714 If a patient answers "yes" to "My specimens may be used for the research described above." question #1 in the model consent, they have consented to participate in the substudy described in Appendix I. The patient should be registered to CALGB - 150714)
In the opinion of the investigator, is the patient eligible
Initial Patient Consent For Specimen Use
Patient's initial consent given for blood specimen use for genetic research on patient's cancer?
In the opinion of the investigator, is the patient eligible
Patient's Initial Consent given for specimen kept for future use in research to learn about, prevent, or treat cancer (model consent question #3)
Patient's Initial Consent given for specimen use for research unrelated to the patient's cancer? (model consent question #4)
Patient's initial consent given for further contact regarding specimen?
Companion Study Calgb - 70501
Did the patient consent to participate in 70501
In the opinion of the investigator, is the patient eligible
Registration Information

Similar models

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial